Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Lotus Eye Hospital and Institute Limited (NSE: LOTUSEYE), ISIN INE947I01017 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
LOTUSEYE last traded at ₹103.00 (-0.95%), with a 52-week range of ₹97.59 to ₹147.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 40.14%, FIIs 0.00%, DIIs 0.02%, mutual funds 0.00%.
EquiSense Score (ECS): 58/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.